Danaher Corporation (NYSE:DHR) is one of the stocks Jim Cramer shed light on. While discussing the stock’s condition over the ...

We recently published 11 Stocks That Jim Cramer Recently Talked About. Danaher Corporation (NYSE:DHR) is one of the stocks ...

Danaher Corporation thrives on bioprocessing demand and diagnostics resilience. Click for why, with solid execution and 80% ...

Danaher Corporation (NYSE:DHR) is one of the best strong buy healthcare stocks to buy now. On July 23, UBS lowered the firm’s ...

Danaher (NYSE:DHR) stock falls even as the company beats Q2 2025 forecasts despite an underperformance at its Life Sciences ...

On October 6, 2023, Danaher Corporation (NYSE:DHR) stock closed at $217.23 per share. One-month return of Danaher Corporation (NYSE:DHR) was -2.04%, and its shares lost 6.25% of their value over ...

Danaher reported revenues of $5.8 billion in the last reported quarter, representing a year-over-year change of -19.1%. EPS of $1.92 for the same period compares with $2.36 a year ago.

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Danaher ( (DHR) ) has issued an update.

Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the quarter ended June 27, 2025. Key Second ...

Danaher India partners with THSTI to build India’s biomanufacturing capacity, drive healthcare innovation, and support affordable life sciences R&D.

On July 9, 2024, Danaher Corporation (NYSE:DHR) stock closed at $239.79 per share with a market capitalization of $177.609 billion.

It's no secret that the industrial sector is facing a difficult 2016, and historically investors have favored stocks such as Danaher Corporation (DHR -2.16%) for their "safe haven" qualities.